19. Oct 2026
Description
(AWP Alliance News) - DKSH has agreed to acquire 100% of NewBridge Pharmaceuticals for an enterprise value of USD 390 million. The Dubai-based healthcare commercialization platform operates in 14 markets across the Middle East and North Africa, extending DKSH's healthcare business beyond Asia Pacific.
NewBridge is expected to generate around USD 385 million in net sales in 2027, with a high-single-digit EBITDA margin. The debt-financed acquisition is expected to close by the end of the first quarter of 2027, subject to customary closing conditions.
The deal is expected to boost DKSH's net sales growth, core EBIT margin and earnings per share from closing.
https://www.publicnow.com/view/3E5F501F70C68FFD672133E7D3C88221A9C9896D…
Disclaimer: This news brief was created using generative artificial intelligence. DKSH Holding AG published the original content used to generate this news brief via EQS News on October 19, 2026, and is solely responsible for the information contained therein.
